LFVN — Lifevantage Corp

Nasdaq · Health Care · Pharmaceuticals · CIK 849146 ·
Last close
$6.93
Market Cap
$87.43M
52W High
$6.94
52W Low
$3.90
ADV30
231,006
Next earnings
LifeVantage Corporation engages in the identification, research, development, formulation, and sale of advanced nutrigenomic activators, dietary supplements, nootropics, weight management, pre and pro-biotics and skin and hair care products internationally. It offers Protandim, a dietary supplement; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 and Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support gut health; LifeVantage IC Bright, a supplement to support eye and brain health, reduce eye fatigue and strain, supports cognitive functions, and support normal sleep patterns; LifeVantage Daily Wellness, a dietary supplement to strengthen immune health; LifeVantage Rise AM and Reset PM System that provides the body with the right nutrients; LifeVantage D3+, a dietary supplement that provides vitamin D3 and K2, magnesium, calcium, and other trace minerals to support a balanced immune system, strong bones, and cardiovascular health; PhysIQ Fat Burn to support weight management; PhysIQ Prebiotic is a dietary supplement designed to support the good bacteria in the gut and a healthy microbiome; MindBody GLP-1 System, a dietary supplement that combines two products, MB Core and MB Enhance, which are designed to support weight management and wellness by activating GLP-1 naturally and balancing signals along the gut-brain axis; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a nootropic energy drink mix. It also provides anti-aging skin care products, such as liquid collagen, facial cleansers, eye cream, moisturizing cream, sunscreen, perfecting lotions, and hand creams, as well as shampoos, nourishing conditioners, and scalp serums under the TrueScience brand name. It sells its products through its website and network of independent consultants. LifeVantage Corporation is based in Lehi, Utah.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGrossProfit OpIncomeNetIncomeAssets CashLiabilities
Mar 2026 43,716,000 34,544,000 1,678,000 1,362,000 62,127,000 12,483,000 28,788,000
Dec 2025 48,931,000 36,209,000 487,000 276,000 61,169,000 10,181,000 28,182,000
Sep 2025 47,561,000 37,816,000 2,268,000 2,155,000 61,579,000 13,091,000 28,422,000
Jun 2025 55,114,000 44,049,000 2,148,000 1,959,000 71,958,000 20,201,000 37,317,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$3,748,000
Investing CF
$-5,796,000
Financing CF
$-9,405,000
CapEx
$-2,053,000
Dividends Paid
$-2,211,000
Buybacks
$-7,477,000
EPS Diluted TTM
$0.60
As of
2026-05-10

Balance + Analyst (yfinance extras)

Retained Earnings
$-103,441,000
Inventory
$18,978,000
Receivables
$4,982,000
ST Investments
EBIT TTM
$8,956,000
Pretax Income TTM
$9,290,000
Interest Exp TTM
Analysts
2

Yahoo Snapshot (yfinance, live)

Total Revenue
$195,323,008
EBITDA
$10,007,000
Free Cash Flow
$2,032,125
Enterprise Value
$68,497,760
Total Cash
$12,483,000
Total Debt
$10,206,000
Shares Out
12,615,822
Trailing EPS
$0.45
Book Value
$2.58
ROE
17.1%
ROA
6.4%
Div Yield
3.59%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOpIncome NetIncomeAssetsLiabilities EquityOCF
Jun 2025 228,530,000 12,199,000 9,805,000 71,958,000 37,317,000 11,878,000
Jun 2024 200,164,000 4,332,000 2,937,000 60,299,000 34,308,000 12,197,000
Jun 2023 213,398,000 4,259,000 2,540,000 66,123,000 31,474,000 6,828,000
Jun 2022 206,360,000 7,575,000 3,120,000 70,706,000 39,190,000 7,959,000
Jun 2021

TTM Snapshot

Revenues TTM
$203,560,000
NetIncome TTM
$5,546,000
OpCashFlow TTM
$0
Assets (Latest)
$60,299,000
Forward EPS
$0.46

Peers — same industry

TickerNameMarket CapLastDaily %
ANVS Annovis Bio, Inc. $87.64M $2.06
CPIX CUMBERLAND PHARMACEUTICALS INC $86.45M $5.77
BHST BIOHARVEST SCIENCES INC. $88.63M $3.91
TELO Telomir Pharmaceuticals, Inc. $88.72M $1.29
FBIO Fortress Biotech, Inc. $89.36M $2.69

News headlines (Yahoo Finance, 1h cache)

Lake Street Capital Markets Downgrades LifeVantage Corporation (LFVN) After Weak Q3 Results
2026-05-14 05:29 · Yahoo
Lifevantage Q3 Earnings Call Highlights
2026-05-07 02:16 · Yahoo
LifeVantage Corporation Q3 2026 Earnings Call Summary
2026-05-07 00:28 · Yahoo
Lifevantage (LFVN) Q3 Earnings and Revenues Miss Estimates
2026-05-06 22:30 · Yahoo
LifeVantage Declares Quarterly Dividend
2026-05-06 20:06 · Yahoo
LifeVantage Announces Financial Results for the Third Quarter of Fiscal 2026
2026-05-06 20:05 · Yahoo
How A Reset Price Target Is Shaping The Evolving Story For LifeVantage (LFVN)
2026-05-03 18:06 · Yahoo
Strength Seen in Lifevantage (LFVN): Can Its 8.5% Jump Turn into More Strength?
2026-04-28 10:48 · Yahoo
Broadwind And 2 Promising Penny Stocks For Your Investment Radar
2026-04-24 18:05 · Yahoo
GrowGeneration Leads The Pack Of 3 Promising Penny Stocks
2026-04-23 18:05 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.